{"id":"https://openalex.org/W3176055828","doi":"https://doi.org/10.1096/fasebj.27.1_supplement.656.9","title":"Negative regulation of A1R\u2010mediated Akt signaling by neurabin","display_name":"Negative regulation of A1R\u2010mediated Akt signaling by neurabin","publication_year":2013,"publication_date":"2013-04-01","ids":{"openalex":"https://openalex.org/W3176055828","doi":"https://doi.org/10.1096/fasebj.27.1_supplement.656.9","mag":"3176055828"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.27.1_supplement.656.9","doi":"https://doi.org/10.1096/fasebj.27.1_supplement.656.9","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.27.1_supplement.656.9","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029968674","display_name":"Yunjia Chen","orcid":"https://orcid.org/0000-0001-9525-6081","observed_orcids":["https://orcid.org/0000-0001-9525-6081"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yunjia Chen","raw_affiliation_strings":["Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079396359","display_name":"Qin Wang","orcid":"https://orcid.org/0000-0002-1079-5914","observed_orcids":["https://orcid.org/0000-0002-1079-5914"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qin Wang","raw_affiliation_strings":["Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I32389192"],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.34915888,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"27","issue":"S1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adenosine-a1-receptor","display_name":"adenosine A1 receptor","score":0.871999979019165},{"id":"https://openalex.org/keywords/akt-signaling","display_name":"Akt signaling","score":0.9419999718666077},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.9629999995231628},{"id":"https://openalex.org/keywords/rgs4","display_name":"RGS4","score":0.9190000295639038},{"id":"https://openalex.org/keywords/adenosine","display_name":"adenosine","score":0.7710000276565552},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9390000104904175},{"id":"https://openalex.org/keywords/erk-activation","display_name":"ERK activation","score":0.7639999985694885},{"id":"https://openalex.org/keywords/antiseizure-effects","display_name":"antiseizure effects","score":0.7379999756813049},{"id":"https://openalex.org/keywords/primary-neurons","display_name":"primary neurons","score":0.6620000004768372}],"concepts":[{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.6759058237075806},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.6054731011390686},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.5961640477180481},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.5277591347694397},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4913000464439392},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37086933851242065},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3576906621456146}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.27.1_supplement.656.9","doi":"https://doi.org/10.1096/fasebj.27.1_supplement.656.9","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.27.1_supplement.656.9","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2758066145","https://openalex.org/W1905139137","https://openalex.org/W3177288327","https://openalex.org/W979601849","https://openalex.org/W2030125834","https://openalex.org/W2740031099","https://openalex.org/W2401842716","https://openalex.org/W2103445837","https://openalex.org/W2594027186","https://openalex.org/W7100585550"],"abstract_inverted_index":{"We":[0,89,118],"have":[1],"recently":[2],"discovered":[3],"a":[4,24,181],"novel":[5],"neural\u2010specific":[6,52],"regulatory":[7],"mechanism":[8,183],"for":[9,184],"fine\u2010tuning":[10],"A1R":[11,28,39,57,79,114,152],"responsiveness":[12],"to":[13,37,74,91],"adenosine.":[14],"A":[15],"neural":[16],"tissue\u2010specific":[17],"protein,":[18],"neurabin,":[19,178],"scaffolds":[20],"the":[21,27,69,94,141,162,191],"formation":[22],"of":[23,31,50,145,166,173,193],"complex":[25,54],"between":[26],"and":[29,59,63,109,125,133,179],"regulator":[30],"G":[32],"Protein":[33],"signaling":[34,40,58,80,176],"4":[35],"(RGS4)":[36],"attenuate":[38],"(Chen":[41],"Y.":[42],"et":[43],"al.,":[44],"2012,":[45],"J.":[46],"Neurosci.":[47],"32(8):2683\u20132695).":[48],"Disruption":[49],"this":[51],"A1R/neurabin/RGS4":[53],"greatly":[55],"enhances":[56],"promotes":[60],"A1R\u2010mediated":[61,128,148,174],"anti\u2010seizure":[62],"neuroprotective":[64,186],"effects":[65],"in":[66,86,102,105,116,121,135,155,190],"mice.":[67],"In":[68],"current":[70],"study,":[71],"we":[72],"aim":[73],"understand":[75],"how":[76],"neurabin":[77,138,146],"regulates":[78],"pathways":[81,104],"that":[82,120],"are":[83],"potentially":[84],"involved":[85],"adenosine\u2010elicited":[87],"neuroprotection.":[88],"chose":[90],"focus":[92],"on":[93],"PI3K\u2010Akt":[95],"pathway,":[96],"which":[97],"plays":[98],"an":[99],"important":[100],"role":[101],"survival":[103],"many":[106],"cell":[107],"systems":[108],"can":[110],"be":[111],"activated":[112],"by":[113,161,177,188],"agonists":[115],"neurons.":[117],"found":[119],"both":[122],"heterologous":[123],"cells":[124,136],"primary":[126],"neurons,":[127],"Akt":[129,149,175],"activation":[130,157],"was":[131,158],"enhanced":[132,185],"prolonged":[134],"without":[137],"expression.":[139],"On":[140],"other":[142],"hand,":[143],"overexpression":[144],"reduced":[147],"activation.":[150],"Meanwhile,":[151],"agonist\u2010dependent":[153],"changes":[154],"ERK":[156],"not":[159],"altered":[160],"presence":[163],"or":[164],"absence":[165,192],"neurabin.":[167,194],"These":[168],"data":[169],"demonstrate":[170],"specific":[171],"regulation":[172],"provide":[180],"potential":[182],"effect":[187],"adenosine":[189]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-07-05T00:00:00"}